Cost impact of BTKi selection in Medicare patients with CLL

That is the title of my paper out today in the Journal of Comparative Effectiveness Research written with co-authors Adam Kittai, Dipen Patel, Nadine Zawadzki, Vikram Shetty, Yazan Barqawi, and Joanna Rhodes. The abstract is below. Aim: To estimate cost savings associated with covalent Bruton’s tyrosine kinase inhibitor (cBTKi) choice in patients with treatment-naive (TN) and…

Read More

Seven Million People with Medicare Spend More Than 10% of Income on Part B Premiums – The Reconciliation Bill Could Drive the Number Higher

People with low incomes and limited financial resources can qualify for the Medicare Savings Programs, through which state Medicaid programs provide financial assistance with Medicare premiums and cost sharing. However, provisions in the GOP’s budget reconciliation bill would make it harder for people to enroll in these programs. Many people with Medicare are facing a…

Read More

The Medicaid Reckoning: Era of Fiscal and Policy Flux

The resilience of Medicaid lies in its complexity. It has resisted large-scale restructuring because it is interwoven with public and private delivery systems. That same complexity now demands a different kind of legal engagement. Medicaid is no longer a silo, but a system-defining platform. The post The Medicaid Reckoning: Era of Fiscal and Policy Flux…

Read More